1,348
Views
2
CrossRef citations to date
0
Altmetric
Clinical Study

Association between serum elastin-derived peptides and abdominal aortic calcification in peritoneal dialysis patients: a cross-sectional study

, , , , , & show all
Pages 860-868 | Received 02 Nov 2020, Accepted 09 Apr 2021, Published online: 17 May 2021

References

  • de Jager DJ, Grootendorst DC, Jager KJ, et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA. 2009;302(16):1782–1789.
  • Ketteler M, Block GA, Evenepoel P, et al. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters. Kidney Int. 2017;92(1):26–36.
  • Avramovski P, Avramovska M, Sotiroski K, Sikole A. Acute-phase proteins as promoters of abdominal aortic calcification in chronic dialysis patients. Saudi J Kidney Dis Transpl. 2019;30(2):376–386.
  • Yao Z, Wang C, Zhang Q, Ma S, Gui B, Duan C. Prevalence of abdominal artery calcification in dialysis patients with end-stage renal disease: a systematic review and meta-analysis. Int Urol Nephrol. 2017;49(11):2061–2069.
  • Liu ZH, for the China Dialysis Calcification Study Group, Yu XQ, Yang JW, et al. Prevalence and risk factors for vascular calcification in Chinese patients receiving dialysis: baseline results from a prospective cohort study. Curr Med Res Opin. 2018;34(8):1491–1500.
  • Wahart A, Hocine T, Albrecht C, et al. Role of elastin peptides and elastin receptor complex in metabolic and cardiovascular diseases. FEBS J. 2019;286(15):2980–2993.
  • Sun Z. Aging, arterial stiffness, and hypertension. Hypertension. 2015;65(2):252–256.
  • Toba H, Lindsey ML. Extracellular matrix roles in cardiorenal fibrosis: potential therapeutic targets for CVD and CKD in the elderly. Pharmacol Ther. 2019;193:99–120.
  • Cocciolone AJ, Hawes JZ, Staiculescu MC, Johnson EO, Murshed M, Wagenseil JE. Elastin, arterial mechanics, and cardiovascular disease. Am J Physiol Heart Circ Physiol. 2018;315(2):H189–H205.
  • Pai A, Leaf EM, El-Abbadi M, Giachelli CM. Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcification in a uremic mouse model of chronic kidney disease. Am J Pathol. 2011;178(2):764–773.
  • Jegatheesan D, Cho Y, Johnson DW. Clinical studies of interventions to mitigate cardiovascular risk in peritoneal dialysis patients. Semin Nephrol. 2018;38(3):277–290.
  • Chung AW, Yang HH, Kim JM, et al. Upregulation of matrix metalloproteinase-2 in the arterial vasculature contributes to stiffening and vasomotor dysfunction in patients with chronic kidney disease. Circulation. 2009;120(9):792–801.
  • Nakagawa D, Zanaty M, Hudson J, et al. Plasma soluble human elastin fragments as an intra-aneurysmal localized biomarker for ruptured intracranial aneurysm. J Am Heart Assoc. 2018;7(17):e010051.
  • Mordi IR, Forsythe RO, Gellatly C, et al. Plasma desmosine and abdominal aortic aneurysm disease. J Am Heart Assoc. 2019;8(20):e013743.
  • Harada K, Suzuki S, Ishii H, et al. Nutrition status predicts severity of vascular calcification in non-dialyzed chronic kidney disease. Circ J. 2017;81(3):316–321.
  • Hendriks EJE, de Jong PA, Beulens JWJ, et al. Annularity of aorto-iliac arterial calcification and risk of all-cause and cardiovascular mortality. JACC Cardiovasc Imaging. 2018;11(11):1718–1719.
  • Wang M, Obi Y, Streja E, et al. Association of parameters of mineral bone disorder with mortality in patients on hemodialysis according to level of residual kidney function. CJASN. 2017;12(7):1118–1127.
  • Labriola L, Wallemacq P, Gulbis B, Jadoul M. The impact of the assay for measuring albumin on corrected ('adjusted') calcium concentrations. Nephrol Dial Transplant. 2009;24(6):1834–1838.
  • de Roij van Zuijdewijn CLM, de Haseth DE, van Dam B, et al. Role of albumin assay on calcium levels and prescription of phosphate binders in chronic hemodialysis patients. Nephron. 2018;140(3):211–217.
  • Ma DH, Yan H, Yang XX, Yu ZZ, Ni ZH, Fang W. Abdominal aortic calcification score as a predictor of clinical outcome in peritoneal dialysis patients: a prospective cohort study. BMC Nephrol. 2020;21(1):151.
  • Makela S, Asola M, Hadimeri H, et al. Abdominal aortic calcifications predict survival in peritoneal dialysis patients. Perit Dial Int. 2018;38(5):366–373.
  • Verbeke F, CORD Study Investigators, Van Biesen W, Honkanen E, et al. Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the Calcification Outcome in Renal Disease (CORD) Study. Clin J Am Soc Nephrol. 2011;6(1):153–159.
  • Baydanoff S, Nicoloff G, Alexiev C. Age-related changes in the level of circulating elastin-derived peptides in serum from normal and atherosclerotic subjects. Atherosclerosis. 1987;66(1-2):163–168.
  • Briet M, Boutouyrie P, Laurent S, London GM. Arterial stiffness and pulse pressure in CKD and ESRD. Kidney Int. 2012;82(4):388–400.
  • Van den Bergh G, Opdebeeck B, D'Haese PC, Verhulst A. The vicious cycle of arterial stiffness and arterial media calcification. Trends Mol Med. 2019;25(12):1133–1146.
  • Mohindra R, Agrawal DK, Thankam FG. Altered vascular extracellular matrix in the pathogenesis of atherosclerosis. J Cardiovasc Transl. 2021. DOI:10.1007/s12265-020-10091-8.
  • Smith ER, Tomlinson LA, Ford ML, et al. Elastin degradation is associated with progressive aortic stiffening and all-cause mortality in predialysis chronic kidney disease. Hypertension. 2012;59(5):973–978.
  • Rabinovich RA, Miller BE, Wrobel K, et al. Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD. Eur Respir J. 2016;47(5):1365–1373.
  • Nikolov A, Tsinlikov I, Nicoloff G, et al. Abnormal levels of age-elastin derived peptides in sera of diabetic patients with arterial hypertension. CEJOI. 2014;39 (3):345–351.
  • Zhou YB, Zhou H, Li L, et al. Hydrogen sulfide prevents elastin loss and attenuates calcification induced by high glucose in smooth muscle cells through suppression of Stat3/Cathepsin S signaling pathway. Int J Mol Sci. 2019;20(17):4202.
  • Hecht E, Freise C, Websky KV, et al. The matrix metalloproteinases 2 and 9 initiate uraemic vascular calcifications. Nephrol Dial Transplant. 2016;31(5):789–797.
  • Figueiredo JL, Aikawa M, Zheng C, et al. Selective cathepsin S inhibition attenuates atherosclerosis in apolipoprotein E-deficient mice with chronic renal disease. Am J Pathol. 2015;185(4):1156–1166.
  • Phinikaridou A, Lacerda S, Lavin B, et al. Tropoelastin: A novel marker for plaque progression and instability. Circ Cardiovasc Imaging. 2018;11(8):e007303.
  • Miekus N, Luise C, Sippl W, Baczek T, Schmelzer CEH, Heinz A. MMP-14 degrades tropoelastin and elastin. Biochimie. 2019;165:32–39.
  • Honkanen E, Kauppila L, Wikstrom B, et al. Abdominal aortic calcification in dialysis patients: results of the CORD study. Nephrol Dial Transpl. 2008;23(12):4009–4015.
  • Chen HC, Chou CY, Lin HJ, Huang CC, Chang CT. Abdominal aortic calcification score predicts the occurrence of coronary artery disease in middle-aged peritoneal dialysis patients. Nephrology (Carlton). 2019;24(3):336–340.
  • Coll B, Betriu A, Martinez-Alonso M, et al. Large artery calcification on dialysis patients is located in the intima and related to atherosclerosis. Clin J Am Soc Nephrol. 2011;6(2):303–310.
  • Lai KJ, Kor CT, Hsieh YP. An inverse relationship between hyperuricemia and mortality in patients undergoing continuous ambulatory peritoneal dialysis. J Clin Med. 2018;7(11):416.
  • Sugano N, Maruyama Y, Ohno I, et al. Effect of uric acid levels on mortality in Japanese peritoneal dialysis patients. Perit Dial Int. 2021;41(3):320–327. .
  • Le Page A, Khalil A, Vermette P, et al. The role of elastin-derived peptides in human physiology and diseases. Matrix Biol. 2019;84:81–96.